[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"laparoscopic-myomectomy\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:laparoscopic-myomectomy":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,39],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":4},"100633361","temporary-uterine-tourniquet-application-versus-local-myometrial-epinephrine-injection-during-laparoscopic-myomectomy-100633361",false,"NCT07525687","Temporary Uterine Tourniquet Application Versus Local Myometrial Epinephrine Injection During Laparoscopic Myomectomy","Inclusion Criteria:\n\n* Female patients aged 18-45 years.\n* Diagnosed with symptomatic uterine leiomyomas requiring laparoscopic myomectomy.\n* Presence of at least one myoma with a diameter ≥3 cm and ≤10 cm.\n* Patients with up to 3 myomas (to standardize surgical complexity).\n* Preoperative hemoglobin level ≥10 g\u002FdL.\n* Ability to provide informed consent.\n\nExclusion Criteria:\n\n* Patients with more than 3 myomas or any myoma larger than 10 cm.\n* Patients with suspected uterine malignancy (e.g., leiomyosarcoma).\n* Patients with known bleeding disorders or on anticoagulant therapy that cannot be safely discontinued.\n* Patients with significant cardiovascular disease, uncontrolled hypertension, or arrhythmias (relative contraindications for epinephrine).\n* Patients with active pelvic infection.\n* Patients with previous extensive uterine surgery (e.g., multiple prior myomectomies or extensive uterine reconstruction) that may compromise uterine integrity.\n* Patients undergoing concurrent major gynecological procedures that might significantly affect blood loss (e.g., hysterectomy, extensive adhesiolysis).\n* Patients with known allergy to epinephrine.\n* Patients unwilling or unable to comply with follow-up protocols.","FEMALE","18 Years","45 Years",{"count":19,"type":20},37,"ESTIMATED","INTERVENTIONAL",[23],"NA","While both local vasoconstrictors and tourniquet application are recognized methods for blood loss control, there is a paucity of head-to-head randomized controlled trials directly comparing these two distinct approaches in laparoscopic myomectomy. Existing data often compare these methods to no intervention or to other less common techniques. A direct comparison is essential to determine which method offers superior hemostasis with an acceptable safety profile in the laparoscopic setting. This study aims to address this gap in the literature.",[26],"Laparoscopic Myomectomy","NOT_YET_RECRUITING","2026-04-06",{"date":30,"type":31},"2026-04-13","ACTUAL",{"date":33,"type":20},"2026-04-20",{"date":35,"type":20},"2027-01-20",{"name":37,"class":38},"Minia University","OTHER",{"id":40,"slug":41,"hasResults":11,"nctId":42,"briefTitle":43,"officialTitle":43,"acronym":4,"eligibilityCriteria":44,"healthyVolunteers":11,"sex":15,"minAge":45,"maxAge":17,"enrollmentInfo":46,"targetDuration":4,"studyType":21,"phases":48,"briefSummary":49,"conditions":50,"keywords":4,"overallStatus":51,"whyStopped":4,"lastUpdateSubmitDate":52,"lastUpdatePostDateStruct":53,"startDateStruct":55,"completionDateStruct":57,"leadSponsor":59,"locationsCount":60},"100608378","reducing-operative-blood-loss-in-laparoscopic-myomectomy-with-umbilico-uterine-trunk-clipping-100608378","NCT07200778","Reducing Operative Blood Loss in Laparoscopic Myomectomy With Umbilico-uterine Trunk Clipping","Inclusion Criteria:\n\n* Age between 19 and 45\n* Symptoms of menorrhagia, pelvic pain, or infertility\n* Plan to have a laparoscopic myomectomy\n* Number of myomas ≤ 4, with the largest myoma measuring ≤ 9 cm\n\nExclusion Criteria:\n\n* Postmenopausal status\n* Dominant pedunculated subserosal FIGO classification (6-7)\n* Submucosal type of myoma FIGO classification (0-2)\n* Suspicion of malignant uterine or adnexal diseases\n* Major medical comorbidities or psychiatric illnesses that could affect follow-up and\u002For compliance\n* Refusal to participate or provide consent to the procedures.","19 Years",{"count":47,"type":20},66,[23],"the purpose of this study is to examine how Umbilico-uterine trunk occlusion reduces surgery-associated blood loss in Laparoscopic Myomectomy.",[26],"RECRUITING","2025-10-01",{"date":54,"type":31},"2025-10-07",{"date":56,"type":31},"2025-09-11",{"date":58,"type":20},"2026-03-11",{"name":37,"class":38},1]